Achieved Net Income and Adjusted EBITDA Growth; Expanded Adjusted EBITDA Margin
Exceeded Pricing Growth Target Above Inflation
Reaffirms 2022 Full-Year Guidance
Cadre Holdings, Inc. (NYSE: CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety and survivability equipment for first responders, announced today its consolidated operating results for the three and nine months ended September 30, 2022.
Third Quarter and Nine-Month 2022 Highlights
- Net sales of $111.6 million for the third quarter; net sales of $334.2 million for the nine months ended September 30, 2022
- Gross profit margin of 39.2% for the third quarter; gross profit margin of 38.0% for the nine months ended September 30, 2022
- Net income of $4.9 million, or $0.13 per diluted share, for the third quarter; net loss of $0.8 million, or $0.02 per diluted share, for the nine months ended September 30, 2022
- Adjusted EBITDA of $20.7 million for the third quarter; Adjusted EBITDA of $53.3 million for the nine months ended September 30, 2022
- Adjusted EBITDA margin of 18.6% for the third quarter; Adjusted EBITDA margin of 16.0% for the nine months ended September 30, 2022
- Adjusted EBITDA conversion of 97% for the third quarter; Adjusted EBITDA conversion of 94% for the nine months ended September 30, 2022
- Declared quarterly cash dividend of $0.08 per share in October 2022
“We are pleased with Cadre’s significant progress in our first 12 months as a public company, delivering on strategic objectives and capitalizing on the attractive long-term tailwinds driving demand for our mission-critical safety and survivability equipment,” said Warren Kanders, CEO and Chairman. “Despite persistent supply chain disruptions and inflationary pressures, Cadre has continued to benefit from its resilient operating model and entrenched positions in law enforcement, first responder, and military markets. During the third quarter, we generated year-over-year and sequential improvements in net income and adjusted EBITDA. Importantly, our product portfolio mix began to improve in Q3 as anticipated, and adjusted EBITDA margin improved by 300 basis points versus Q2.”
“Cadre once again exceeded our 1% pricing growth target above inflation, helping to drive outstanding adjusted EBITDA conversion above the high-end of our guidance range. Based on our continued strong cash flow generation, we remain well positioned to capitalize on a robust M&A pipeline, complementing our core organic growth initiatives. Building on our two accretive acquisitions year-to-date, we continue actively pursuing attractive acquisitions and remain steadfast in our focus on high margin companies with leading market positions and strong recurring revenues and cash flows for the benefit of shareholders.”
Third Quarter and Nine-Month 2022 Operating Results
For the quarter ended September 30, 2022, Cadre generated net sales of $111.6 million, as compared to $98.7 million for the quarter ended September 30, 2021. The increase in the product segment was primarily the result of recent acquisitions and armor volume partially offset by a large contractual armor order that was fulfilled in the prior year, and in our distribution segment, the increase was driven by agency demand for hard goods.
For the nine months ended September 30, 2022, Cadre generated net sales of $334.2 million, as compared to $323.8 million for the prior year period, mainly driven by distribution volume, and recent acquisitions, offset by prior year US Federal and crowd control shipments.
For the quarter ended September 30, 2022, Cadre generated gross profit of $43.7 million, as compared to $39.3 million for the quarter ended September 30, 2021. For the nine months ended September 30, 2022, Cadre generated gross profit of $127.2 million, as compared to $131.5 million for the prior year period.
Gross profit margin was 39.2% for the quarter ended September 30, 2022, as compared to 39.8% for the quarter ended September 30, 2021. Gross profit margin was 38.0% for the nine months ended September 30, 2022, as compared to 40.6% for the prior year period, mainly driven by 91 basis points from the amortization of inventory step-up recorded as part of the recent acquisitions and less favorable mix, partially offset by pricing in excess of material inflation.
Net income was $4.9 million for the quarter ended September 30, 2022, as compared to a net loss of $5.3 million for the quarter ended September 30, 2021. The increase resulted primarily from improved revenue and the loss on extinguishment of debt related to the August 2021 debt refinance.
Net loss was $0.8 million for the nine months ended September 30, 2022, as compared to net income of $8.4 million for the prior year period, primarily as a result of stock-based compensation expense and unfavorable product and portfolio mix.
Cadre generated $20.7 million of Adjusted EBITDA for the quarter ended September 30, 2022, as compared to $15.4 million for the quarter ended September 30, 2021. Adjusted EBITDA margin was 18.6% for the quarter ended September 30, 2022, as compared to 15.6% for the prior year period.
Cadre generated $53.3 million of Adjusted EBITDA for the nine months ended September 30, 2022, as compared to $56.1 million for the prior year period. Adjusted EBITDA margin was 16.0% for the nine months ended September 30, 2022, as compared to 17.3% for the prior year period.
Product segment gross margin was 41.6% and 40.2% for the third quarter and first nine months of 2022, respectively, compared to 40.5% and 41.6% for the respective prior year periods.
Distribution segment gross margin was 19.8% and 20.9% for the third quarter and first nine months of 2022, respectively, compared to 24.6% and 25.2% for the respective prior year periods.
Liquidity, Cash Flows and Capital Allocation
- Cash and cash equivalents increased by $2.5 million from $33.9 million as of December 31, 2021 to $36.4 million as of September 30, 2022.
- Total debt decreased by $6.6 million from $159.7 million as of December 31, 2021, to $153.1 million as of September 30, 2022.
- Net debt (total debt net of cash and cash equivalents) decreased by $9.0 million from $125.8 million as of December 31, 2021, to $116.8 million as of September 30, 2022.
- Capital expenditures totaled $0.7 million for the third quarter and $3.2 million for the nine months ended September 30, 2022, compared with $0.7 million for the third quarter and $2.2 million for the nine months ended September 30, 2021.
Dividend
On October 20, 2022, the Company announced that its Board of Directors declared a quarterly cash dividend of $0.08 per share, or $0.32 per share on an annualized basis. Cadre's dividend payment will be made on November 14, 2022, to shareholders of record as of the close of business on the record date of November 1, 2022. The declaration of any future dividend is subject to the discretion of the Company's Board of Directors.
2022 Outlook
For the full year 2022, Cadre expects to generate net sales in the range of $444.0 million to $452.0 million and Adjusted EBITDA in the range of $72.5 million and $77.5 million. Cadre expects Adjusted EBITDA conversion in the range of 92-95% for the full year.
Conference Call
Cadre management will host a conference call on Thursday, November 10, 2022, at 5:00 PM EST to discuss the latest corporate developments and financial results. The dial-in number for callers in the US is (888)-510-2553 and the dial-in number for international callers is 646-960-0473. The access code for all callers is 1410384. A live webcast will also be available on the Company’s website at https://www.cadre-holdings.com/.
A replay of the call will be available through November 24, 2022. To access the replay, please dial 800-770-2030 in the U.S. or +1-647-362-9199 if outside the U.S., and then enter the access code 1410384.
About Cadre
Headquartered in Jacksonville, Florida, Cadre is a global leader in the manufacturing and distribution of safety and survivability products for first responders. Cadre's equipment provides critical protection to allow users to safely and securely perform their duties and protect those around them in hazardous or life-threatening situations. The Company's core products include body armor, explosive ordnance disposal equipment, and duty gear. Our highly engineered products are utilized in over 100 countries by federal, state and local law enforcement, fire and rescue professionals, explosive ordnance disposal teams, and emergency medical technicians. Our key brands include Safariland® and Med-Eng®, amongst others.
Use of Non-GAAP Measures
The Company reports its financial results in accordance with U.S. generally accepted accounting principles (“GAAP”). The press release contains the non-GAAP measures: (i) earnings before interest, taxes, other income or expense, depreciation and amortization (“EBITDA”), (ii) adjusted EBITDA, (iii) adjusted EBITDA margin, (iv) adjusted EBITDA conversion rate and (v) LTM adjusted EBITDA. The Company believes the presentation of these non-GAAP measures provides useful information for the understanding of its ongoing operations and enables investors to focus on period- over-period operating performance, and thereby enhances the user’s overall understanding of the Company’s current financial performance relative to past performance and provides, along with the nearest GAAP measures, a baseline for modeling future earnings expectations. Non-GAAP measures are reconciled to comparable GAAP financial measures within this press release. The Company cautions that non-GAAP measures should be considered in addition to, but not as a substitute for, the Company’s reported GAAP results. Additionally, the Company notes that there can be no assurance that the above referenced non-GAAP financial measures are comparable to similarly titled financial measures used by other publicly traded companies.
Forward-Looking Statements
Except for historical information, certain matters discussed in this press release may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include but are not limited to all projections and anticipated levels of future performance. Forward-looking statements involve risks, uncertainties and other factors that may cause our actual results to differ materially from those discussed herein. Any number of factors could cause actual results to differ materially from projections or forward-looking statements, including without limitation, changes to global, social and political economic conditions, spending patterns of government agencies, competitive pressures, the impact of acquisitions and related integration activities, logistical challenges related to disruptions and delays, product liability claims, the success of new product introductions, currency exchange rate fluctuations and the risks of doing business in the markets in which we operate, including foreign countries. More information on potential factors that could affect the Company’s financial results are more fully described from time to time in the Company’s public reports filed with the Securities and Exchange Commission, including the Company’s Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and Current Reports on Form 8-K. All forward-looking statements included in this press release are based upon information available to the Company as of the date of this press release, and speak only as of the date hereof. We assume no obligation to update any forward-looking statements to reflect events or circumstances after the date of this press release.
|
CADRE HOLDINGS, INC.
CONSOLIDATED BALANCE SHEETS
(Unaudited)
(In thousands, except share and per share amounts)
|
|
|
|
|
|
|
|
|
|
|
|
September 30, 2022
|
|
December 31, 2021
|
|
Assets
|
|
|
|
|
|
|
|
Current assets
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
$
|
36,350
|
|
$
|
33,857
|
|
Accounts receivable, net of allowance for doubtful accounts of $774 and $645, respectively
|
|
|
55,759
|
|
|
48,344
|
|
Inventories
|
|
|
79,246
|
|
|
63,978
|
|
Prepaid expenses
|
|
|
8,740
|
|
|
10,353
|
|
Other current assets
|
|
|
7,493
|
|
|
3,171
|
|
Assets held for sale
|
|
|
225
|
|
|
278
|
|
Total current assets
|
|
|
187,813
|
|
|
159,981
|
|
Property and equipment, net of accumulated depreciation and amortization of $41,478 and $37,171, respectively
|
|
|
45,671
|
|
|
33,053
|
|
Deferred tax assets, net
|
|
|
5,350
|
|
|
7,059
|
|
Intangible assets, net
|
|
|
51,518
|
|
|
42,415
|
|
Goodwill
|
|
|
77,196
|
|
|
66,262
|
|
Other assets
|
|
|
7,631
|
|
|
3,026
|
|
Total assets
|
|
$
|
375,179
|
|
$
|
311,796
|
|
|
|
|
|
|
|
|
|
Liabilities, Mezzanine Equity and Shareholders' Equity
|
|
|
|
|
|
|
|
Current liabilities
|
|
|
|
|
|
|
|
Accounts payable
|
|
$
|
24,523
|
|
$
|
19,328
|
|
Accrued liabilities
|
|
|
35,515
|
|
|
40,736
|
|
Income tax payable
|
|
|
957
|
|
|
1,255
|
|
Liabilities held for sale
|
|
|
91
|
|
|
128
|
|
Current portion of long-term debt
|
|
|
13,285
|
|
|
13,174
|
|
Total current liabilities
|
|
|
74,371
|
|
|
74,621
|
|
Long-term debt
|
|
|
139,818
|
|
|
146,516
|
|
Deferred tax liabilities
|
|
|
3,526
|
|
|
1,297
|
|
Other liabilities
|
|
|
904
|
|
|
722
|
|
Total liabilities
|
|
|
218,619
|
|
|
223,156
|
|
|
|
|
|
|
|
|
|
Mezzanine equity
|
|
|
|
|
|
|
|
Preferred stock ($0.0001 par value, 10,000,000 shares authorized, no shares issued and outstanding as of September 30, 2022 and December 31, 2021)
|
|
|
—
|
|
|
—
|
|
|
|
|
|
|
|
|
|
Shareholders' equity
|
|
|
|
|
|
|
|
Common stock ($0.0001 par value, 190,000,000 shares authorized, 37,332,271 and 34,383,350 shares issued and outstanding as of September 30, 2022 and December 31, 2021, respectively)
|
|
|
4
|
|
|
3
|
|
Additional paid-in capital
|
|
|
203,754
|
|
|
127,606
|
|
Accumulated other comprehensive loss
|
|
|
(846)
|
|
|
(1,917)
|
|
Accumulated deficit
|
|
|
(46,352)
|
|
|
(37,052)
|
|
Total shareholders’ equity
|
|
|
156,560
|
|
|
88,640
|
|
Total liabilities, mezzanine equity and shareholders' equity
|
|
$
|
375,179
|
|
$
|
311,796
|
|
CADRE HOLDINGS, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
(In thousands, except share and per share amounts)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended September 30,
|
|
Nine Months Ended September 30,
|
|
|
|
2022
|
|
2021
|
|
2022
|
|
2021
|
|
Net sales
|
|
$
|
111,554
|
|
$
|
98,654
|
|
$
|
334,192
|
|
$
|
323,751
|
|
Cost of goods sold
|
|
|
67,814
|
|
|
59,346
|
|
|
207,042
|
|
|
192,256
|
|
Gross profit
|
|
|
43,740
|
|
|
39,308
|
|
|
127,150
|
|
|
131,495
|
|
Operating expenses
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Selling, general and administrative
|
|
|
31,732
|
|
|
27,673
|
|
|
118,431
|
|
|
87,168
|
|
Restructuring and transaction costs
|
|
|
1,578
|
|
|
(49)
|
|
|
3,380
|
|
|
1,491
|
|
Related party expense
|
|
|
112
|
|
|
142
|
|
|
1,346
|
|
|
437
|
|
Total operating expenses
|
|
|
33,422
|
|
|
27,766
|
|
|
123,157
|
|
|
89,096
|
|
Operating income
|
|
|
10,318
|
|
|
11,542
|
|
|
3,993
|
|
|
42,399
|
|
Other expense
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense
|
|
|
(1,567)
|
|
|
(3,464)
|
|
|
(4,496)
|
|
|
(14,129)
|
|
Loss on extinguishment of debt
|
|
|
—
|
|
|
(15,155)
|
|
|
—
|
|
|
(15,155)
|
|
Other expense, net
|
|
|
(1,851)
|
|
|
(352)
|
|
|
(2,812)
|
|
|
(881)
|
|
Total other expense, net
|
|
|
(3,418)
|
|
|
(18,971)
|
|
|
(7,308)
|
|
|
(30,165)
|
|
Income (loss) before provision for income taxes
|
|
|
6,900
|
|
|
(7,429)
|
|
|
(3,315)
|
|
|
12,234
|
|
(Provision) benefit for income taxes
|
|
|
(1,959)
|
|
|
2,123
|
|
|
2,536
|
|
|
(3,861)
|
|
Net income (loss)
|
|
$
|
4,941
|
|
$
|
(5,306)
|
|
$
|
(779)
|
|
$
|
8,373
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
0.13
|
|
$
|
(0.19)
|
|
$
|
(0.02)
|
|
$
|
0.30
|
|
Diluted
|
|
$
|
0.13
|
|
$
|
(0.19)
|
|
$
|
(0.02)
|
|
$
|
0.30
|
|
Weighted average shares outstanding:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
37,289,880
|
|
|
27,483,350
|
|
|
35,697,891
|
|
|
27,483,350
|
|
Diluted
|
|
|
37,747,613
|
|
|
27,483,350
|
|
|
35,697,891
|
|
|
27,483,350
|
|
CADRE HOLDINGS, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
(In thousands)
|
|
|
|
|
|
|
Nine Months Ended September 30,
|
|
|
|
2022
|
|
2021
|
|
Cash Flows From Operating Activities:
|
|
|
|
|
|
|
|
Net (loss) income
|
|
$
|
(779)
|
|
$
|
8,373
|
|
Adjustments to reconcile net (loss) income to net cash provided by operating activities:
|
|
|
|
|
|
|
|
Depreciation and amortization
|
|
|
11,319
|
|
|
10,426
|
|
Amortization of original issue discount and debt issue costs
|
|
|
554
|
|
|
2,483
|
|
Amortization of inventory step-up
|
|
|
3,055
|
|
|
—
|
|
Loss on extinguishment of debt
|
|
|
—
|
|
|
15,155
|
|
Deferred income taxes
|
|
|
(2,755)
|
|
|
1,533
|
|
Stock-based compensation
|
|
|
28,988
|
|
|
—
|
|
Provision for (recoveries from) losses on accounts receivable
|
|
|
245
|
|
|
(254)
|
|
Foreign exchange loss
|
|
|
3,006
|
|
|
45
|
|
Changes in operating assets and liabilities, net of impact of acquisitions:
|
|
|
|
|
|
|
|
Accounts receivable
|
|
|
(3,271)
|
|
|
1,549
|
|
Inventories
|
|
|
(7,187)
|
|
|
(10,261)
|
|
Prepaid expenses and other assets
|
|
|
986
|
|
|
(4,642)
|
|
Accounts payable and other liabilities
|
|
|
(4,660)
|
|
|
6,582
|
|
Net cash provided by operating activities
|
|
|
29,501
|
|
|
30,989
|
|
Cash Flows From Investing Activities:
|
|
|
|
|
|
|
|
Purchase of property and equipment
|
|
|
(2,938)
|
|
|
(2,225)
|
|
Business acquisitions, net of cash acquired
|
|
|
(55,039)
|
|
|
—
|
|
Net cash used in investing activities
|
|
|
(57,977)
|
|
|
(2,225)
|
|
Cash Flows From Financing Activities:
|
|
|
|
|
|
|
|
Proceeds from revolving credit facilities
|
|
|
43,000
|
|
|
248,000
|
|
Principal payments on revolving credit facilities
|
|
|
(43,000)
|
|
|
(223,132)
|
|
Proceeds from term loans
|
|
|
—
|
|
|
198,735
|
|
Principal payments on term loans
|
|
|
(7,514)
|
|
|
(224,547)
|
|
Proceeds from insurance premium financing
|
|
|
3,989
|
|
|
4,269
|
|
Principal payments on insurance premium financing
|
|
|
(3,878)
|
|
|
(2,611)
|
|
Payment of capital leases
|
|
|
(26)
|
|
|
(32)
|
|
Payments for debt issuance costs
|
|
|
—
|
|
|
(2,830)
|
|
Payments on extinguishment of debt
|
|
|
—
|
|
|
(4,215)
|
|
Taxes paid in connection with employee stock transactions
|
|
|
(6,216)
|
|
|
—
|
|
Proceeds from secondary offering, net of underwriter discounts
|
|
|
56,329
|
|
|
—
|
|
Deferred offering costs
|
|
|
(2,953)
|
|
|
—
|
|
Dividends distributed
|
|
|
(8,521)
|
|
|
(9,996)
|
|
Net cash provided by (used in) financing activities
|
|
|
31,210
|
|
|
(16,359)
|
|
Effect of foreign exchange rates on cash and cash equivalents
|
|
|
(241)
|
|
|
(3)
|
|
Change in cash and cash equivalents
|
|
|
2,493
|
|
|
12,402
|
|
Cash and cash equivalents, beginning of period
|
|
|
33,857
|
|
|
2,873
|
|
Cash and cash equivalents, end of period
|
|
$
|
36,350
|
|
$
|
15,275
|
|
Supplemental Disclosure of Cash Flows Information:
|
|
|
|
|
|
|
|
Cash paid for income taxes, net
|
|
$
|
710
|
|
$
|
695
|
|
Cash paid for interest
|
|
$
|
3,860
|
|
$
|
8,524
|
|
Supplemental Disclosure of Non-Cash Investing and Financing Activities:
|
|
|
|
|
|
|
|
Accruals and accounts payable for capital expenditures
|
|
$
|
272
|
|
$
|
—
|
|
CADRE HOLDINGS, INC.
SEGMENT INFORMATION
(Unaudited)
(In thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine months ended September 30, 2022
|
|
|
|
|
|
|
|
|
|
Reconciling
|
|
|
|
|
|
|
Products
|
|
Distribution
|
|
Items(1)
|
|
Total
|
|
Net sales
|
|
$
|
277,941
|
|
$
|
73,836
|
|
$
|
(17,585)
|
|
$
|
334,192
|
|
Cost of goods sold
|
|
|
166,192
|
|
$
|
58,437
|
|
$
|
(17,587)
|
|
|
207,042
|
|
Gross profit
|
|
$
|
111,749
|
|
$
|
15,399
|
|
$
|
2
|
|
$
|
127,150
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine months ended September 30, 2021
|
|
|
|
|
|
|
|
|
|
Reconciling
|
|
|
|
|
|
|
Products
|
|
Distribution
|
|
Items(1)
|
|
Total
|
|
Net sales
|
|
$
|
274,039
|
|
$
|
69,086
|
|
$
|
(19,374)
|
|
$
|
323,751
|
|
Cost of goods sold
|
|
|
159,924
|
|
|
51,696
|
|
|
(19,364)
|
|
|
192,256
|
|
Gross profit
|
|
$
|
114,115
|
|
$
|
17,390
|
|
$
|
(10)
|
|
$
|
131,495
|
|
(1)
|
|
Reconciling items consist primarily of intercompany eliminations and items not directly attributable to operating segments.
|
|
CADRE HOLDINGS, INC.
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES
(Unaudited)
(In thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year ended
December 31,
|
|
Three Months Ended June 30,
|
|
Three Months Ended
September 30,
|
|
Nine Months Ended
September 30,
|
|
Last Twelve Months
|
|
|
|
|
2021
|
|
2022
|
|
2022
|
|
2021
|
|
2022
|
|
2021
|
|
September 30, 2022
|
|
|
Net income (loss)
|
|
$
|
12,661
|
|
$
|
4,445
|
|
$
|
4,941
|
|
$
|
(5,306)
|
|
$
|
(779)
|
|
$
|
8,373
|
|
$
|
3,509
|
|
|
Add back:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization
|
|
|
13,718
|
|
|
3,836
|
|
|
3,939
|
|
|
3,406
|
|
|
11,319
|
|
|
10,426
|
|
|
14,611
|
|
|
Interest expense
|
|
|
16,425
|
|
|
1,439
|
|
|
1,567
|
|
|
3,464
|
|
|
4,496
|
|
|
14,129
|
|
|
6,792
|
|
|
Provision (benefit) for income taxes
|
|
|
6,531
|
|
|
1,517
|
|
|
1,959
|
|
|
(2,123)
|
|
|
(2,536)
|
|
|
3,861
|
|
|
134
|
|
|
EBITDA
|
|
$
|
49,335
|
|
$
|
11,237
|
|
$
|
12,406
|
|
$
|
(559)
|
|
$
|
12,500
|
|
$
|
36,789
|
|
$
|
25,046
|
|
|
Add back:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Restructuring and transaction costs(1)
|
|
|
3,430
|
|
|
2,203
|
|
|
1,578
|
|
|
(49)
|
|
|
4,380
|
|
|
1,491
|
|
|
6,319
|
|
|
Loss on extinguishment of debt(2)
|
|
|
15,155
|
|
|
—
|
|
|
—
|
|
|
15,155
|
|
|
—
|
|
|
15,155
|
|
|
—
|
|
|
Other expense, net(3)
|
|
|
947
|
|
|
756
|
|
|
1,851
|
|
|
352
|
|
|
2,812
|
|
|
881
|
|
|
2,878
|
|
|
Stock-based compensation expense(4)
|
|
|
355
|
|
|
2,818
|
|
|
2,820
|
|
|
—
|
|
|
29,361
|
|
|
—
|
|
|
29,716
|
|
|
Stock-based compensation payroll tax expense(5)
|
|
|
—
|
|
|
7
|
|
|
—
|
|
|
—
|
|
|
305
|
|
|
—
|
|
|
305
|
|
|
LTIP bonus(6)
|
|
|
2,162
|
|
|
174
|
|
|
375
|
|
|
524
|
|
|
933
|
|
|
1,804
|
|
|
1,291
|
|
|
Amortization of inventory step-up(7)
|
|
|
—
|
|
|
1,191
|
|
|
1,711
|
|
|
—
|
|
|
3,055
|
|
|
—
|
|
|
3,055
|
|
|
Adjusted EBITDA
|
|
$
|
71,384
|
|
$
|
18,386
|
|
$
|
20,741
|
|
$
|
15,423
|
|
$
|
53,346
|
|
$
|
56,120
|
|
$
|
68,610
|
|
|
Less: Capital expenditures
|
|
|
(3,029)
|
|
|
(1,421)
|
|
|
(720)
|
|
|
(719)
|
|
|
(3,210)
|
|
|
(2,225)
|
|
|
(4,014)
|
|
|
Adjusted EBITDA less capital expenditures
|
|
$
|
68,355
|
|
$
|
16,965
|
|
$
|
20,021
|
|
$
|
14,704
|
|
$
|
50,136
|
|
$
|
53,895
|
|
$
|
64,596
|
|
|
Adjusted EBITDA conversion rate(8)
|
|
|
96
|
%
|
|
92
|
%
|
|
97
|
%
|
|
95
|
%
|
|
94
|
%
|
|
96
|
%
|
|
94
|
%
|
|
Adjusted EBITDA margin(9)
|
|
|
16.7
|
%
|
|
15.6
|
%
|
|
18.6
|
%
|
|
15.6
|
%
|
|
16.0
|
%
|
|
17.3
|
%
|
|
|
|
|
(1)
|
|
Reflects the “Restructuring and transaction costs” line item on our consolidated statement of operations, which primarily includes transaction costs composed of legal and consulting fees, and $1.0 million paid to Kanders & Company, Inc., a company controlled by our Chief Executive Officer, for services related to the acquisition of Cyalume, which is included in related party expense in the Company’s consolidated statements of operations and comprehensive income (loss).
|
|
(2)
|
|
Reflects losses incurred in connection with the August 2021 debt refinancing.
|
|
(3)
|
|
Reflects the “Other expense, net” line item on our consolidated statement of operations. For the three and nine months September 30, 2022 and 2021, other expense, net primarily includes losses on foreign currency transactions.
|
|
(4)
|
|
Reflects compensation expense related to equity and liability classified stock-based compensation plans.
|
|
(5)
|
|
Reflects payroll taxes associated with vested stock-based compensation awards.
|
|
(6)
|
|
Reflects the cost of a cash-based long-term incentive plan awarded to employees that vests over three years.
|
|
(7)
|
|
Reflects amortization expense related to the step-up inventory adjustment recorded as part of the recent acquisitions.
|
|
(8)
|
|
Reflects (Adjusted EBITDA less capital expenditures) / Adjusted EBITDA.
|
|
(9)
|
|
Reflects Adjusted EBITDA / Net Sales for the relevant periods.
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20221110005846/en/